Indacrinone: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Indacrinone.svg|Indacrinone | |||
File:Indacrinone_Enantiomers.png|Indacrinone Enantiomers | |||
File:Indacrinone_synthesis.svg|Indacrinone Synthesis | |||
</gallery> | |||
Latest revision as of 01:34, 18 February 2025
Indacrinone is a diuretic medication that is primarily used in the treatment of congestive heart failure. It belongs to the class of drugs known as loop diuretics, which work by preventing the absorption of salt and fluid in the kidneys, thereby promoting diuresis (the production of urine).
Pharmacology[edit]
Indacrinone acts on the ascending limb of the loop of Henle in the kidneys. It inhibits the sodium-potassium-chloride cotransporter (NKCC2) located on the luminal membrane, which leads to a decrease in the reabsorption of sodium and chloride ions. This results in an increase in the excretion of these ions, along with water, leading to increased urine output.
Clinical Use[edit]
Indacrinone is used in the management of congestive heart failure, where it helps to alleviate symptoms such as edema (swelling) and dyspnea (shortness of breath) by reducing fluid overload in the body. It may also be used in the treatment of hypertension (high blood pressure), although other drugs are generally preferred for this indication.
Side Effects[edit]
Like other loop diuretics, indacrinone can cause a number of side effects. These may include hypokalemia (low potassium levels), hyponatremia (low sodium levels), and hypomagnesemia (low magnesium levels). It can also cause dehydration and hypotension (low blood pressure), particularly in elderly patients or those with impaired kidney function.
Contraindications[edit]
Indacrinone is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with severe kidney disease, liver disease, or electrolyte imbalances.


